Immunogenicity and Safety of One Dose of HPV Vaccine

Inclusion Criteria: * Female, aged between 9 and 14 years (including 9 and 14 years) on the day of enrollment * Judged as healthy and eligible for vaccination by the investigators through a self- reported medical history and some physical examinations * Subjects and legal guardians are informed and agree, and sign the Informed Consent Form * Female urine pregnancy test is negative Exclusion Criteria: * Axillary temperature\>37.2 ℃ * Other investigational or unregistered products (drugs or vaccines) that have been used or planned to be used during the study period within 30 days prior to receiving the research vaccine * Systemic use of immunosuppressants or other immunomodulatory drugs or corticosteroids for a long period of time (lasting for more than 14 days) within 6 months prior to receiving the research vaccine, but local use is allowed (such as ointments, eye drops, inhalers, or nasal sprays) * Within 3 months prior to vaccination, immunoglobulin and/or blood preparations were used or planned to be used during the study period, but emergency use of tetanus immunoglobulin and rabies immunoglobulin is allowed after exposure * Received inactivated vaccines within 14 days prior to enrollment in the study, or received live vaccines within 21 days prior to enrollment in the study * Fever (axillary temperature ≥ 38.0 ℃) within 3 days prior to vaccination, or any acute illness requiring systemic antibiotics or antiviral treatment within the past 5 days * Previously received H…